Your browser doesn't support javascript.
loading
In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer.
Alamri, Ahmad M; Alkhilaiwi, Faris A; Khan, Najeeb U; Tasleem, Munazzah.
Affiliation
  • Alamri AM; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, 61413, Saudi Arabia.
  • Alkhilaiwi FA; Cancer Research Unit, King Khalid University, Abha, 61413, Saudi Arabia.
  • Khan NU; Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
  • Tasleem M; Regenerative Medicine Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Anticancer Agents Med Chem ; 23(19): 2111-2126, 2023.
Article in En | MEDLINE | ID: mdl-37287303

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Achyranthes / Proto-Oncogene Proteins B-raf / GTP Phosphohydrolases / Membrane Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Anticancer Agents Med Chem Journal subject: ANTINEOPLASICOS / QUIMICA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Achyranthes / Proto-Oncogene Proteins B-raf / GTP Phosphohydrolases / Membrane Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Anticancer Agents Med Chem Journal subject: ANTINEOPLASICOS / QUIMICA Year: 2023 Document type: Article Affiliation country: